BAILEY BRANDT: Open Payments
NPI 1215278361 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,111 in 58 payments from 12 companies in 2025. Trend: 2023 $1,502 · 2024 $1,441 · 2025 $1,111
Food & beverage: $1,111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $428 |
| Organon LLC | 2 | $174 |
| GENZYME CORPORATION | 7 | $140 |
| Lilly USA, LLC | 3 | $66 |
| Galderma Laboratories, L.P. | 3 | $64 |
| Janssen Biotech, Inc. | 3 | $53 |
| UCB, Inc. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| Arcutis Biotherapeutics, Inc. | 2 | $28 |
Products named: RINVOQ, SKYRIZI, VTAMA, DUPIXENT, TALTZ, NEMLUVIO, TREMFYA, Bimzelx.
Industry payments across OR — which companies pay providers there.
